查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1837382

外科黏合剂市场按产品类型、配方、应用和最终用户划分 - 全球预测 2025-2032 年

Surgical Glue Market by Product Type, Formulation, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，外科黏合剂市场规模将达到 132.1 亿美元，复合年增长率为 11.21%。

主要市场统计数据
基准年2024年 56.4亿美元
预计年份：2025年 62.9亿美元
预测年份：2032年 132.1亿美元
复合年增长率 (%) 11.21%

权威地阐述了现代外科黏合剂技术、监管变化和临床需求如何重新定义围手术全期黏合剂策略。

外科黏合剂的应用范围已从单纯的伤口缝合辅助工具发展成为现代围手术全期策略的核心多功能工具。临床医生现在不仅将这些产品视为止血剂和密封剂，还将其视为实现微创手术、提高手术效率以及减少在精细解剖结构中对缝合线依赖性的关键手段。配方技术和给药系统的进步拓展了其在各个专科的潜在临床应用，迫使医院董事会、门诊中心和诊所重新思考其采购和临床管道。

同时，法律规范和报销政策也随之调整，以反映生技药品和合成化学品在临床价值上的差异，并适应新型器械-药物组合。临床创新与政策演变的交汇，使得供应商策略和产品开发成为医疗机构决策的重中之重。因此，从临床领导者到供应链经理，相关人员要求更清晰的证据，以证明产品的相对性能、在不同手术环境中的易用性以及与现有工作流程的兼容性。

展望未来，该领域的发展轨迹将取决于製造商如何平衡生物功能与操作实用性。能够显着缩短手术时间、降低併发症发生率或实现新型微创手术的创新将影响临床应用。临床证据的产生、监管定位和实际应用便利性之间的策略协调将决定哪些产品能够在外科手术通讯协定中占据长期偏好。

材料突破、改进的输送平台以及不断变化的监管重点如何加速外科黏合剂的普及应用并重新定义标准

外科黏合剂的变化反映了材料科学、递送工程和临床实践三者融合的趋势，这些趋势正在重新定义止血和组织缝合的预期。改进的生物黏合剂化学性质使黏合剂的功能超越了简单的密封，能够与组织微环境相互作用，在促进癒合的同时最大限度地减少发炎反应。同时，透过客製化劣化曲线和调节合成平台的机械性能，临床医生能够在从血管修復到眼科果冻等各种应用中，使黏合剂的性能与组织的生物力学特性相匹配。

给药方式的创新同样重要。单组分、双组分、即用型混合型以及先进贴片技术的普及，为临床医生提供了更多选择，以应对手术的复杂性和操作限制。气雾剂和喷射喷雾剂型拓展了黏合剂的效用，使其能够应用于微创手术等对精准度和用量要求极高的领域。黏合剂的应用范围曾经仅限于普通外科手术，如今已扩展到心血管、整形外科、牙科和眼科等手术领域，缩短了手术时间，并改善了复杂解剖结构的暴露。

监管机构和支付者正在积极应对，强调具有临床意义的终点指标，例如减少术后併发症和提高手术效率，而不是仅仅关注基准指标。因此，製造商正优先考虑完善的临床路径和真实世界证据的收集。这些技术和系统变革并非渐进式的，而是将催生一种新的护理标准，该标准取决于黏合剂的选择、与手术流程的整合以及患者获益的证实。

评估近期关税变化对外科黏合剂价值链供应链、采购动态和创新计画的连锁反应

针对医疗设备进口征收关税将对外科黏合剂生态系统产生复杂且连锁的影响，尤其是在供应链、成本和采购管道方面。关税将增加依赖跨境生产的零件和成品的到岸成本，促使製造商重新评估筹资策略和供应商合约。为此，许多公司正在加大近岸外包和双重采购力度，以降低贸易政策波动带来的风险；而另一些公司则正在加快关键合成和配方流程的在地化进程，以保持对医院采购团队的价格竞争力。

除了直接的成本影响外，关税还会使预算有限且报销週期固定的医疗系统在采购决策方面变得更加复杂。采购主管在评估品牌生物黏合剂与成本更低的合成替代品时，面临着更艰难的权衡，并且越来越要求进行透明的「总成本护理」分析，该分析应考虑采购价格、手术时间节省、避免併发症以及急性后期资源利用情况。由于关税会改变与供应商的谈判动态，因此，那些拥有灵活的分销策略并与综合物流合作伙伴签订长期合约的供应商在维持供应的连续性和价格的可预测性方面具有比较优势。

在营运层面，关税也会影响创新计画。考虑对新生产线或配方升级进行资本投资的公司，在建立预期收益和製定定价策略时，必须将关税导致的成本变化纳入考量。这种动态促使研发、製造和商业团队加快协作，优先考虑那些对供应链影响较小或可在国内生产的技术。总而言之，关税作为一种强制机制，正在再形成整个外科黏合剂产业的供应链架构、采购谈判和长期投资决策。

透过深入的細項分析，将产品化学成分、配方、临床用途和最终用户优先顺序与外科手术环境中可操作的推广管道联繫起来。

透过精细的细分视角，我们可以发现不同产品类型、配方、临床应用和终端用户环境下的效能和应用动态存在差异——每种情况都有其独特的操作和临床优先事项。按产品类型划分，生物黏合剂（例如白蛋白和纤维蛋白胶）往往更注重亲和性和固有止血活性，因此更适用于易出血或血管丰富的组织；而合成黏合剂（例如氰基丙烯酸酯和聚乙二醇水凝胶）则更注重可预测的机械强度、生产规模的降解性和合理的生产规模化能力。临床医生通常会在组织相容性、操作特性和储存稳定性之间权衡，从而选择合适的化学成分。

製剂配方差异进一步影响临床效用。液体製剂包括给药时混合的双组分系统和便于操作的单组分製剂。贴片技术提供天然和合成基质，除了黏着性外，还能提供机械支撑。喷雾製剂，无论是气溶胶还是喷射喷雾，都适用于表面覆盖和微创操作，在这些情况下，精确定位和均匀分布至关重要。每种製剂都会影响手术室的工作流程、训练要求以及与辅助器具（例如施用器和内视镜端口）的兼容性。

应用趋势表明，黏合剂的选择与手术目标密切相关。在心臟瓣膜置换术和血管修復等心血管手术中，黏合剂必须兼顾密封完整性和血液接触相容性；而在牙科和眼科手术中，微精度和低接触毒性至关重要。腹部和胸部等普通外科手术需要能够适应多种组织类型并承受动态机械环境的黏合剂。整形外科应用，例如骨固定和关节修復，则需要具有结构加固潜力并能与固定硬体整合的产品。

终端用户细分凸显了不同的采购驱动因素。无论是医院所有还是独立运作的门诊手术中心，都优先考虑快速固化、易于使用且能支援高吞吐量的配方。门诊和专科诊所则寻求基础设施要求低、储存条件明确的黏合剂。公立和私立医院会从配製流程、临床委员会核准以及与机构通讯协定的兼容性等方面评估黏合剂。这些细分为产品开发、实证策略和商业化方法提供了依据，使其与临床实务相契合。

区域对比分析着重阐述了美洲、欧洲、中东和非洲以及亚太地区的动态将如何影响监管互动、采购和临床应用管道。

区域动态将对外科黏合剂的应用管道、监管互动和分销策略产生不同的影响。在美洲，先进的医院系统和门诊医疗服务的发展推动了对能够提高效率和微创手术的黏合剂的需求，而监管机构和报销机制也越来越倾向于那些能够减少併发症和提高手术效率的证据。这使得临床数据、外科医生培训计画和供应链可靠性成为商业性成功的关键。

监管协调和采购模式多样化正在欧洲、中东和非洲形成多种不同的应用模式。该地区的高所得市场优先考虑临床疗效和透过既定手术流程实现的互通性，而新兴医疗体系则强调成本效益和供应的连续性。製造商必须应对不同的监管管道，并根据当地临床意见领袖的需求调整沟通策略，同时也要考虑生技药品的物流和低温运输要求。

在亚太地区，医疗基础设施的异质性以及外科手术能力的快速发展，为优质、高性价比的黏合剂技术创造了机会。该地区庞大的手术量和对微创手术的投入，有利于可扩展的合成平台和本地化生产合作。同时，监管机构对可靠临床证据的要求日益提高，促使供应商投资于区域性临床试验和上市后监测计画。这些区域差异影响着全球营运公司的市场进入模式、商业资源分配和临床证据倡议。

竞争与营运情报重点阐述了产品差异化、主导应用和供应链韧性将如何决定外科黏合剂产业的领导地位。

外科黏合剂领域的竞争动态主要集中在产品差异化、实证医学证据的累积以及透过培训和稳定的供应来支持临床应用的能力。领先的创新者倾向于投资转化研究，将实验室性能与可验证的临床结果联繫起来，从而向医院董事会和外科负责人讯息清晰的讯息。那些透过施用器系统、临床医生培训计画和完善的上市后监测来完善产品系列的公司，能够更有效地吸引关键意见领袖和机构买家的注意。

策略伙伴关係和授权协议在加速产品进入临床试验阶段和扩大分销管道方面发挥关键作用。利用经销商网路或与医疗器材製造商合作开发联合交付平台的公司，通常能够获得更广泛的临床试验机会，并在心血管和眼科手术等专科领域更快地被市场接受。此外，那些协调临床、监管和商业团队，以产生可操作证据（例如器械对比测试和真实世界性能指标）的机构，往往能够缩短产品推广週期。

在製造和供应链管理方面表现卓越，能够帮助企业在相关人员压力下脱颖而出。那些能够维持稳定前置作业时间、严格遵守品质系统并具备灵活生产能力的企业，更有可能获得医院和门诊中心的长期合约。此外，企业能否在处方笺和长期供应商名单中保持优先地位，越来越取决于其对使用成本和整体流程影响的关注程度，而不仅仅是采购价格。

为製造商和医疗保健采购领导者提供切实可行的策略指导，以协调创新、供应链韧性和商业模式，从而加速临床应用。

产业领导者应制定一项策略，将研发、监管规划和商业性执行有机结合，以加速产品推广应用并降低供应风险。旨在满足高精度显微外科手术需求和更广泛的普通外科手术适应症的产品，将提升产品生命週期价值并简化培训流程。此类技术设计应辅以强有力的、具有临床意义的证据计划，重点关注与采购委员会相关的成果，例如降低併发症和提高工作流程效率。

其次，我们透过地域分散的生产和策略供应商合作来增强供应链韧性。将关键合成流程外包到近岸地区并寻找多种原料来源，可以降低关税造成的成本波动和物流中断风险。同时，投资标准化施用器和培训模组，可以减少使用者操作技术的差异，并加快临床医生认证流程。

第三，商业化策略应与终端使用者的优先事项保持一致。门诊手术中心和诊所强调易用性、储存便利性和手术效率。医院则强调与临床路径的整合、配药流程、长期价值评估。最后，共用结果为导向的商业模式，例如批量采购协议和共享绩效指标的试验计画，以减少推广阻力，并创造可衡量的成功案例，从而在整个医疗系统中推广应用。

采用稳健的混合方法研究途径，结合临床医生访谈、监管指南审查和证据三角验证，以产出可操作的产业情报。

本研究采用混合方法，将一手质性研究资料与严谨的二手检验结合，以确保研究结果具有临床基础和实际应用价值。一手研究包括对各专科的执业外科医生、门诊中心和医院的采购负责人以及监管和临床运营方面的高级专家进行结构化访谈。这些访谈提供了超越实验室性能数据的背景信息，重点关注实际应用中的操作特性、配方决策标准以及推动产品应用的临床终点。

二次检验包括对同行评审的临床文献、相关监管指南文件和临床试验註册资料进行全面审查，以支援产品性能描述和安全性概况。在适用情况下，也审查了程序指南和共识声明，以确保产品声明与临床最佳实践相符。资料三角验证确保从访谈中获得的经验性见解得到已发表证据的支持，并符合多个地区观察到的一致实践模式。

透过跨职能的同侪评审，确保了分析的严谨性，评审人员包括来自临床、监管和商业领域的专家。采用细分映射法将产品属性与临床和最终用户需求相匹配，并应用敏感度分析来解读关税和供应链情境。这种调查方法建构了一个情境化的依证，旨在为策略决策提供支持，而无需依赖单一来源的断言。

对临床创新、监管预期和供应弹性如何决定长期应用和策略定位进行批判性综合分析

外科黏合剂正日趋成熟，成为具有战略意义的临床工具，其价值不仅限于简单的止血，还包括优化工作流程、提高器械相容性以及改善患者预后。生技药品和合成化学製剂的改进，以及製剂和递送方式的创新，为临床医生提供了一套全面的套件，以满足各种手术的机械和生物学需求。同时，采购和监管环境也日益注重结果导向，要求供应商证明其产品在实际应用中的效果和营运效益。

不断变化的供应链现状和政策凸显了具有韧性的生产策略和灵活的商业化模式的重要性。那些积极将临床证据的产生与营运可靠性相结合，并调整其市场推广策略的企业，将更有利于影响临床通讯协定的製定，并确保长期的采购承诺。最终，在这个领域取得持久成功需要一种整体性的方法，将科学、临床效用和切实可行的商业性执行相结合，并以证据为支撑，以持续稳定的供应为保障。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 在门诊环境中，氰基丙烯酸酯组织黏合剂的应用日益广泛，以加速伤口缝合。
  • 利用奈米颗粒技术增强外科黏合剂的抗菌性能
  • 开发可生物降解的止血外科黏合剂以减少术后併发症
  • 紫外光固化外科黏合剂因其在微创手术中实现精确组织黏合而日益受到关注。
  • 製药公司与医疗设备製造商结成策略联盟，共同创新外科黏合剂
  • 先进密封剂监管核准的增加将推动新兴国家市场扩张。

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

第八章 按产品类型分類的外科黏合剂市场

  • 生物黏合剂
    • 白蛋白
    • 纤维蛋白胶
  • 合成胶黏剂
    • 氰基丙烯酸酯
    • 聚乙二醇水凝胶

9. 按配方分類的外科黏合剂市场

  • 液体
    • 双组分
    • 一种液体
  • 修补
    • 自然补丁
    • 合成补丁
  • 喷
    • 气雾剂
    • 喷射

第十章 按应用分類的外科黏合剂市场

  • 心血管外科
    • 心臟瓣膜置换术
    • 血管修復
  • 牙科
  • 一般外科
    • 腹部手术
    • 胸腔外科
  • 眼科手术
  • 整形外科
    • 骨固定
    • 关节修復

第十一章 依最终用户分類的外科黏合剂市场

  • 门诊手术中心
    • 医院所属的门诊手术中心
    • 独立ASC
  • 诊所
    • 门诊部
    • 专科诊所
  • 医院
    • 私立医院
    • 公立医院

第十二章 各地区外科黏合剂市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 外科黏合剂市场（按类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国外科黏合剂市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Ethicon, Inc.
    • Medtronic plc
    • B. Braun Melsungen AG
    • 3M Company
    • Baxter International Inc
    • Smith & Nephew plc
    • CryoLife, Inc.
    • Integra LifeSciences Corporation
    • Adhezion Biomedical, LLC
    • Cohera Medical, Inc.
Product Code: MRR-0355054AC4C4

The Surgical Glue Market is projected to grow by USD 13.21 billion at a CAGR of 11.21% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.64 billion
Estimated Year [2025] USD 6.29 billion
Forecast Year [2032] USD 13.21 billion
CAGR (%) 11.21%

An authoritative orientation to how contemporary surgical glue technologies, regulatory shifts, and clinical expectations are redefining perioperative adhesion strategies

The landscape of surgical adhesives has evolved from simple wound closure adjuncts to multifunctional tools central to modern perioperative strategy. Clinicians now view these products not merely as hemostatic or sealing agents but as enablers of minimally invasive approaches, faster throughput, and reduced reliance on sutures in delicate anatomies. Advances in formulation technology and delivery systems have expanded clinical applicability across specialties, prompting hospital committees, ambulatory centers, and clinics to reassess procurement and clinical pathways.

Concurrently, regulatory frameworks and reimbursement considerations have adjusted to reflect the differentiated clinical value of biologic versus synthetic chemistries and to accommodate novel device-drug combination formats. This intersection of clinical innovation and policy evolution places supplier strategy and product development at the forefront of institutional decision-making. As a result, stakeholders from clinical leaders to supply chain managers demand clearer evidence of comparative performance, ease of use in diverse operative environments, and compatibility with existing workflows.

Looking forward, the sector's trajectory will be defined by how manufacturers balance biofunctionality with operational practicality. Innovations that meaningfully reduce procedure time, lower complication rates, or enable new minimally invasive techniques will influence clinical adoption. Strategic alignment between clinical evidence generation, regulatory positioning, and on-the-ground usability will determine which products establish durable preference within surgical protocols.

How materials breakthroughs, refined delivery platforms, and evolving regulatory focus are collectively accelerating adoption and redefining standards for surgical adhesives

The transformation of the surgical adhesive landscape reflects converging forces in materials science, delivery engineering, and clinical practice that collectively redefine expectations for hemostasis and tissue approximation. Improvements in bioadhesive chemistries have enabled adhesives to do more than seal; they now interact with tissue microenvironments to support healing while minimizing inflammatory response. At the same time, synthetic platforms increasingly offer tailored degradation profiles and tunable mechanical properties, allowing clinicians to match adhesive performance with tissue biomechanics in applications ranging from vascular repair to ophthalmic microsurgery.

Delivery innovations have been equally pivotal. The proliferation of single-component liquids, dual-component systems that mix at point of application, and advanced patch technologies provide clinicians with options that align with procedural complexity and access constraints. Aerosol and jet spray modalities extend the utility of adhesives to minimally invasive settings where precision and low-volume application matter. These shifts have also stimulated cross-disciplinary adoption: adhesives once confined to general surgery now feature in cardiovascular, orthopedic, dental, and ophthalmic practices because they can reduce operative time and improve handling in complex anatomies.

Regulatory and payer landscapes have responded by emphasizing clinically meaningful endpoints, such as reduction of postoperative complications and improvements in procedural efficiency, rather than focusing solely on bench metrics. Consequently, manufacturers are prioritizing robust clinical pathways and real-world evidence collection. Taken together, these technological and systemic changes are not incremental; they are enabling new standards of care that hinge on adhesive selection, integration into surgical workflows, and demonstrable patient benefit.

Assessing the ripple effects of recent tariff changes on supply chains, procurement dynamics, and innovation planning across the surgical adhesive value chain

The introduction of tariff measures targeting medical device imports has complex, cascading implications for the surgical adhesives ecosystem, most notably through supply chain, cost, and procurement pathways. Tariffs elevate landed costs for components and finished goods that rely on cross-border manufacturing, prompting manufacturers to reassess sourcing strategies and supplier agreements. In response, many companies intensify nearshoring or dual-sourcing efforts to mitigate exposure to trade policy volatility, while others accelerate localization of critical synthesis and formulation steps to preserve price competitiveness for hospital procurement teams.

Beyond direct cost effects, tariffs complicate purchasing decisions within health systems that operate under constrained budgets and fixed reimbursement schedules. Procurement executives face tougher trade-offs when evaluating branded biologic adhesives versus lower-cost synthetic alternatives, and they increasingly demand transparent total-cost-of-care analyses that account for acquisition price, procedure time savings, complication avoidance, and postacute resource utilization. Because tariffs can shift vendor negotiation dynamics, suppliers that maintain flexible distribution strategies and long-term contracts with integrated logistics partners gain a comparative advantage in sustaining supply continuity and predictable pricing.

Operationally, tariffs also influence innovation planning. Firms contemplating capital investments in new manufacturing lines or formulation upgrades must factor in tariff-induced cost volatility when modeling expected returns and pricing strategies. This dynamic accelerates collaboration between R&D, manufacturing, and commercial teams to prioritize technologies that are less supply-chain sensitive or that can be produced domestically. In sum, tariffs function as a forcing mechanism that reshapes supply chain architecture, procurement negotiations, and long-term investment decisions across the surgical adhesive sector.

Insightful segmentation analysis that maps product chemistries, formulations, clinical applications, and end-user priorities to practical adoption pathways across surgical settings

A granular segmentation lens reveals distinct performance and adoption dynamics across product categories, formulations, clinical applications, and end-user settings, each with its own operational and clinical priorities. Based on product type, biologic adhesives-characterized by albumin and fibrin sealant variants-tend to emphasize biocompatibility and intrinsic hemostatic activity, making them preferred in bleeding-prone or highly vascularized tissues, whereas synthetic adhesives such as cyanoacrylate and polyethylene glycol hydrogel prioritize predictable mechanical strength, controllable degradation, and streamlined manufacturing scalability. Clinicians often choose between these chemistries by weighing tissue compatibility against handling characteristics and storage stability.

Formulation differences further stratify clinical utility. Liquid formats are available as both dual-component systems that mix at the point of delivery and single-component preparations with simplified handling; patch technologies offer natural and synthetic substrates that provide mechanical support in addition to adhesion; and spray delivery, whether aerosol spray or jet spray, caters to surface coverage and minimally invasive access where precise placement and uniform distribution matter. Each formulation influences operating-room workflow, training needs, and device compatibility with adjunctive tools such as applicators or endoscopic ports.

Application-specific trends demonstrate how adhesive choice aligns with surgical objectives. In cardiovascular procedures, including heart valve replacement and vascular repair, adhesives must balance seal integrity with blood-contact compatibility, while in dental and ophthalmic contexts, microprecision and low-contact toxicity are paramount. General surgery applications such as abdominal and thoracic procedures require adhesives that perform across varied tissue types and that tolerate dynamic mechanical environments. Orthopedic indications like bone fixation and joint repair demand products with structural reinforcement potential and integration with fixation hardware.

End-user segmentation underscores divergent procurement drivers. Ambulatory surgical centers, whether hospital owned or independent, prioritize fast-setting, easy-to-use formulations that support high throughput. Clinics, both outpatient and specialty, seek adhesives with minimal infrastructure demands and clear storage profiles. Hospitals, whether private or public, evaluate adhesives through the lenses of formulary processes, clinical committee endorsement, and compatibility with institutional protocols. Together, these segmentation dimensions inform product development, evidence generation strategies, and commercialization approaches tailored to real-world practice.

Comparative regional intelligence revealing how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics shape regulatory engagement, procurement, and clinical adoption pathways

Regional dynamics influence adoption pathways, regulatory engagement, and distribution strategies for surgical adhesives in distinct ways. In the Americas, advanced hospital systems and ambulatory care growth drive demand for adhesives that support efficiency gains and minimally invasive procedures, while regulatory agencies and reimbursement mechanisms increasingly favor evidence that demonstrates reductions in complications and improved procedural throughput. This creates a landscape where clinical data, surgeon training programs, and supply chain reliability are central to commercial success.

Across Europe, the Middle East & Africa, regulatory harmonization and varying procurement models produce a mosaic of adoption patterns. High-income markets within this region prioritize clinical outcomes and interoperability with established surgical workflows, whereas emerging healthcare systems emphasize cost-effectiveness and supply continuity. Manufacturers must navigate diverse regulatory pathways and tailor engagement strategies to local clinical opinion leaders, while also considering logistics and cold-chain requirements for biologic chemistries.

In Asia-Pacific, heterogeneous healthcare infrastructures and rapid expansion of surgical capacity create opportunities for both premium and cost-efficient adhesive technologies. The region's large procedural volumes and investment in minimally invasive surgery favor scalable synthetic platforms and localized manufacturing partnerships. At the same time, regulatory agencies increasingly require robust clinical evidence, prompting suppliers to invest in region-specific trials and post-market surveillance initiatives. These regional distinctions shape go-to-market models, allocation of commercial resources, and clinical evidence strategies for firms operating globally.

Competitive and operational intelligence highlighting how product differentiation, evidence-driven adoption, and supply chain resilience determine leadership in the surgical adhesive sector

Competitive dynamics in the surgical adhesive sector center on product differentiation, evidence generation, and the ability to support clinical adoption through training and supply reliability. Leading innovators tend to invest in translational research that connects bench performance with demonstrable clinical outcomes, enabling clearer messaging to hospital committees and surgical leaders. Companies that complement product portfolios with applicator systems, clinician training programs, and robust post-market surveillance create stronger pull through key opinion leaders and institutional buyers.

Strategic partnerships and licensing arrangements play a prominent role in accelerating time-to-clinic and expanding distribution reach. Firms that leverage distributor networks or form alliances with device manufacturers for co-developed delivery platforms often achieve broader trial access and faster uptake in specialty areas such as cardiovascular and ophthalmic surgery. Moreover, organizations that align clinical affairs, regulatory, and commercial teams to generate pragmatic evidence-such as comparative device studies and real-world performance metrics-tend to shorten the adoption curve.

Operational excellence in manufacturing and supply chain management differentiates companies under pressure from procurement stakeholders. Those that demonstrate consistent lead times, quality systems compliance, and flexible production capacity are more likely to be selected for long-term contracts by hospitals and ambulatory centers. Finally, a clear focus on cost-to-use and total procedural impact rather than acquisition price alone increasingly determines which companies sustain preferred status in formularies and long-term supplier lists.

Actionable strategic guidance for manufacturers and healthcare procurement leaders to align innovation, supply resilience, and commercial models for accelerated clinical adoption

Industry leaders should pursue a coordinated strategy that aligns R&D, regulatory planning, and commercial execution to accelerate adoption and mitigate supply risks. First, prioritize development of platform technologies that offer modularity across applications; products designed to serve both high-precision microsurgical needs and broader general surgery indications deliver greater lifecycle value and streamline training. Complement these technical designs with robust, clinically meaningful evidence plans that emphasize outcomes relevant to procurement committees, such as complication reduction and workflow efficiency.

Second, strengthen supply chain resilience through geographically diversified manufacturing and strategic supplier partnerships. Nearshoring critical synthesis steps and qualifying multiple raw-material sources will reduce exposure to tariff-induced cost swings and logistics disruptions. Concurrently, invest in standardized applicators and training modules that reduce variability in user technique and accelerate institutional credentialing, thereby shortening the conversion timeline from trial to formulary inclusion.

Third, tailor commercialization tactics to end-user priorities. For ambulatory surgical centers and outpatient clinics, emphasize ease of use, storage simplicity, and procedural throughput; for hospitals, focus on integration with clinical pathways, formulary processes, and long-term value assessments. Finally, implement outcome-oriented commercial models, such as bundled purchasing agreements or pilot programs with shared performance metrics, to reduce adoption friction and create measurable proof points that can be scaled across health systems.

Robust mixed-methods research approach combining clinician interviews, regulatory guidance review, and evidence triangulation to produce actionable sector intelligence

The research synthesis relies on a mixed-methods approach that integrates primary qualitative inputs with rigorous secondary validation to ensure findings are both clinically grounded and operationally actionable. Primary research included structured interviews with practicing surgeons across specialties, procurement leaders from ambulatory centers and hospitals, and senior regulatory and clinical affairs professionals. These conversations focused on real-world handling characteristics, formulary decision criteria, and clinical endpoints that drive adoption, providing context beyond bench performance data.

Secondary validation encompassed a comprehensive review of peer-reviewed clinical literature, relevant regulatory guidance documents, and clinical trial registries to corroborate performance narratives and safety profiles. Where applicable, procedural guidelines and consensus statements were examined to align product claims with accepted clinical best practices. Data triangulation ensured that anecdotal insights from interviews were supported by published evidence or consistent practice patterns observed across multiple geographies.

Analytical rigor was maintained through cross-functional peer review involving clinical, regulatory, and commercial subject-matter experts. Segmentation mapping was used to align product attributes with clinical and end-user requirements, and sensitivity checks were applied to interpret tariff and supply chain scenarios. This methodology delivered a contextualized evidence base intended to support strategic decision-making without relying on single-source assertions.

Conclusive synthesis of how clinical innovation, regulatory expectations, and supply resilience collectively determine long-term adoption and strategic positioning

Surgical adhesives are maturing into strategic clinical tools whose value extends beyond simple hemostasis to encompass workflow optimization, device compatibility, and patient outcome improvement. The ongoing refinement of biologic and synthetic chemistries, coupled with innovations in formulation and delivery, offers clinicians a broader toolkit tuned to the mechanical and biological requirements of diverse procedures. Meanwhile, procurement and regulatory environments are increasingly outcome-focused, compelling suppliers to demonstrate real-world impact and operational advantages.

Supply chain realities and policy shifts underscore the importance of resilient manufacturing strategies and flexible commercialization models. Organizations that proactively align clinical evidence generation with operational reliability and tailored go-to-market approaches are best positioned to influence clinical protocols and secure long-term procurement commitments. In conclusion, durable success in this sector requires a holistic approach that integrates science, clinical utility, and pragmatic commercial execution-anchored by evidence and reinforced by supply continuity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of cyanoacrylate-based tissue adhesives for faster wound closure in outpatient settings
  • 5.2. Technological integration of nanoparticles to enhance antimicrobial properties in surgical glues
  • 5.3. Development of biodegradable and hemostatic surgical adhesives to reduce post-surgical complications
  • 5.4. Growing focus on UV-curable surgical glues for precise tissue bonding in minimally invasive procedures
  • 5.5. Strategic partnerships between pharmaceutical companies and medical device manufacturers to innovate surgical adhesives
  • 5.6. Increasing regulatory approvals for advanced sealants driving market expansion in emerging economies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Glue Market, by Product Type

  • 8.1. Biological Adhesive
    • 8.1.1. Albumin
    • 8.1.2. Fibrin Sealant
  • 8.2. Synthetic Adhesive
    • 8.2.1. Cyanoacrylate
    • 8.2.2. Polyethylene Glycol Hydrogel

9. Surgical Glue Market, by Formulation

  • 9.1. Liquid
    • 9.1.1. Dual Component
    • 9.1.2. Single Component
  • 9.2. Patch
    • 9.2.1. Natural Patch
    • 9.2.2. Synthetic Patch
  • 9.3. Spray
    • 9.3.1. Aerosol Spray
    • 9.3.2. Jet Spray

10. Surgical Glue Market, by Application

  • 10.1. Cardiovascular Surgery
    • 10.1.1. Heart Valve Replacement
    • 10.1.2. Vascular Repair
  • 10.2. Dental
  • 10.3. General Surgery
    • 10.3.1. Abdominal Procedures
    • 10.3.2. Thoracic Procedures
  • 10.4. Ophthalmic Surgery
  • 10.5. Orthopedic Surgery
    • 10.5.1. Bone Fixation
    • 10.5.2. Joint Repair

11. Surgical Glue Market, by End User

  • 11.1. Ambulatory Surgical Center
    • 11.1.1. Hospital Owned ASC
    • 11.1.2. Independent ASC
  • 11.2. Clinic
    • 11.2.1. Outpatient Clinic
    • 11.2.2. Specialty Clinic
  • 11.3. Hospital
    • 11.3.1. Private Hospital
    • 11.3.2. Public Hospital

12. Surgical Glue Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Surgical Glue Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Surgical Glue Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Ethicon, Inc.
    • 15.3.2. Medtronic plc
    • 15.3.3. B. Braun Melsungen AG
    • 15.3.4. 3M Company
    • 15.3.5. Baxter International Inc
    • 15.3.6. Smith & Nephew plc
    • 15.3.7. CryoLife, Inc.
    • 15.3.8. Integra LifeSciences Corporation
    • 15.3.9. Adhezion Biomedical, LLC
    • 15.3.10. Cohera Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL GLUE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL GLUE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SURGICAL GLUE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL GLUE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS SURGICAL GLUE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL SURGICAL GLUE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. SURGICAL GLUE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. SURGICAL GLUE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SURGICAL GLUE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SURGICAL GLUE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL GLUE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL GLUE MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL GLUE MARKET SIZE, BY ALBUMIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL GLUE MARKET SIZE, BY ALBUMIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL GLUE MARKET SIZE, BY ALBUMIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL GLUE MARKET SIZE, BY ALBUMIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL GLUE MARKET SIZE, BY ALBUMIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL GLUE MARKET SIZE, BY FIBRIN SEALANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL GLUE MARKET SIZE, BY FIBRIN SEALANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL GLUE MARKET SIZE, BY FIBRIN SEALANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL GLUE MARKET SIZE, BY FIBRIN SEALANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL GLUE MARKET SIZE, BY FIBRIN SEALANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL GLUE MARKET SIZE, BY FIBRIN SEALANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL GLUE MARKET SIZE, BY CYANOACRYLATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL GLUE MARKET SIZE, BY CYANOACRYLATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL GLUE MARKET SIZE, BY CYANOACRYLATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL GLUE MARKET SIZE, BY CYANOACRYLATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL GLUE MARKET SIZE, BY CYANOACRYLATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL GLUE MARKET SIZE, BY CYANOACRYLATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL GLUE MARKET SIZE, BY POLYETHYLENE GLYCOL HYDROGEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL GLUE MARKET SIZE, BY POLYETHYLENE GLYCOL HYDROGEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL GLUE MARKET SIZE, BY POLYETHYLENE GLYCOL HYDROGEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL GLUE MARKET SIZE, BY POLYETHYLENE GLYCOL HYDROGEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL GLUE MARKET SIZE, BY POLYETHYLENE GLYCOL HYDROGEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL GLUE MARKET SIZE, BY POLYETHYLENE GLYCOL HYDROGEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL GLUE MARKET SIZE, BY DUAL COMPONENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL GLUE MARKET SIZE, BY DUAL COMPONENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL GLUE MARKET SIZE, BY DUAL COMPONENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL GLUE MARKET SIZE, BY DUAL COMPONENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL GLUE MARKET SIZE, BY DUAL COMPONENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL GLUE MARKET SIZE, BY DUAL COMPONENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL GLUE MARKET SIZE, BY SINGLE COMPONENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL GLUE MARKET SIZE, BY SINGLE COMPONENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL GLUE MARKET SIZE, BY SINGLE COMPONENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL GLUE MARKET SIZE, BY SINGLE COMPONENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL GLUE MARKET SIZE, BY SINGLE COMPONENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL GLUE MARKET SIZE, BY SINGLE COMPONENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL GLUE MARKET SIZE, BY NATURAL PATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL GLUE MARKET SIZE, BY NATURAL PATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL GLUE MARKET SIZE, BY NATURAL PATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL GLUE MARKET SIZE, BY NATURAL PATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL GLUE MARKET SIZE, BY NATURAL PATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL GLUE MARKET SIZE, BY NATURAL PATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC PATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC PATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC PATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC PATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC PATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC PATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL GLUE MARKET SIZE, BY AEROSOL SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL GLUE MARKET SIZE, BY AEROSOL SPRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL GLUE MARKET SIZE, BY AEROSOL SPRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL GLUE MARKET SIZE, BY AEROSOL SPRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SURGICAL GLUE MARKET SIZE, BY AEROSOL SPRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SURGICAL GLUE MARKET SIZE, BY AEROSOL SPRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SURGICAL GLUE MARKET SIZE, BY JET SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL GLUE MARKET SIZE, BY JET SPRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SURGICAL GLUE MARKET SIZE, BY JET SPRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SURGICAL GLUE MARKET SIZE, BY JET SPRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SURGICAL GLUE MARKET SIZE, BY JET SPRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SURGICAL GLUE MARKET SIZE, BY JET SPRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SURGICAL GLUE MARKET SIZE, BY HEART VALVE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL GLUE MARKET SIZE, BY HEART VALVE REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SURGICAL GLUE MARKET SIZE, BY HEART VALVE REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SURGICAL GLUE MARKET SIZE, BY HEART VALVE REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SURGICAL GLUE MARKET SIZE, BY HEART VALVE REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SURGICAL GLUE MARKET SIZE, BY HEART VALVE REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SURGICAL GLUE MARKET SIZE, BY VASCULAR REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SURGICAL GLUE MARKET SIZE, BY VASCULAR REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SURGICAL GLUE MARKET SIZE, BY VASCULAR REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SURGICAL GLUE MARKET SIZE, BY VASCULAR REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SURGICAL GLUE MARKET SIZE, BY VASCULAR REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SURGICAL GLUE MARKET SIZE, BY VASCULAR REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SURGICAL GLUE MARKET SIZE, BY DENTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SURGICAL GLUE MARKET SIZE, BY DENTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SURGICAL GLUE MARKET SIZE, BY DENTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SURGICAL GLUE MARKET SIZE, BY DENTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SURGICAL GLUE MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SURGICAL GLUE MARKET SIZE, BY DENTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SURGICAL GLUE MARKET SIZE, BY ABDOMINAL PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SURGICAL GLUE MARKET SIZE, BY ABDOMINAL PROCEDURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SURGICAL GLUE MARKET SIZE, BY ABDOMINAL PROCEDURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SURGICAL GLUE MARKET SIZE, BY ABDOMINAL PROCEDURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SURGICAL GLUE MARKET SIZE, BY ABDOMINAL PROCEDURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SURGICAL GLUE MARKET SIZE, BY ABDOMINAL PROCEDURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SURGICAL GLUE MARKET SIZE, BY THORACIC PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SURGICAL GLUE MARKET SIZE, BY THORACIC PROCEDURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SURGICAL GLUE MARKET SIZE, BY THORACIC PROCEDURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SURGICAL GLUE MARKET SIZE, BY THORACIC PROCEDURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SURGICAL GLUE MARKET SIZE, BY THORACIC PROCEDURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SURGICAL GLUE MARKET SIZE, BY THORACIC PROCEDURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SURGICAL GLUE MARKET SIZE, BY OPHTHALMIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SURGICAL GLUE MARKET SIZE, BY OPHTHALMIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SURGICAL GLUE MARKET SIZE, BY OPHTHALMIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SURGICAL GLUE MARKET SIZE, BY OPHTHALMIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SURGICAL GLUE MARKET SIZE, BY OPHTHALMIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SURGICAL GLUE MARKET SIZE, BY OPHTHALMIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SURGICAL GLUE MARKET SIZE, BY BONE FIXATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SURGICAL GLUE MARKET SIZE, BY BONE FIXATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SURGICAL GLUE MARKET SIZE, BY BONE FIXATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SURGICAL GLUE MARKET SIZE, BY BONE FIXATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SURGICAL GLUE MARKET SIZE, BY BONE FIXATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SURGICAL GLUE MARKET SIZE, BY BONE FIXATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SURGICAL GLUE MARKET SIZE, BY JOINT REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SURGICAL GLUE MARKET SIZE, BY JOINT REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SURGICAL GLUE MARKET SIZE, BY JOINT REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SURGICAL GLUE MARKET SIZE, BY JOINT REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SURGICAL GLUE MARKET SIZE, BY JOINT REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SURGICAL GLUE MARKET SIZE, BY JOINT REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SURGICAL GLUE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL OWNED ASC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL OWNED ASC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL OWNED ASC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL OWNED ASC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL OWNED ASC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL OWNED ASC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SURGICAL GLUE MARKET SIZE, BY INDEPENDENT ASC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SURGICAL GLUE MARKET SIZE, BY INDEPENDENT ASC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SURGICAL GLUE MARKET SIZE, BY INDEPENDENT ASC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SURGICAL GLUE MARKET SIZE, BY INDEPENDENT ASC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL SURGICAL GLUE MARKET SIZE, BY INDEPENDENT ASC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL SURGICAL GLUE MARKET SIZE, BY INDEPENDENT ASC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL SURGICAL GLUE MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL SURGICAL GLUE MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL SURGICAL GLUE MARKET SIZE, BY OUTPATIENT CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL SURGICAL GLUE MARKET SIZE, BY OUTPATIENT CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL SURGICAL GLUE MARKET SIZE, BY OUTPATIENT CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL SURGICAL GLUE MARKET SIZE, BY OUTPATIENT CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL SURGICAL GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL SURGICAL GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL SURGICAL GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL SURGICAL GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL SURGICAL GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL SURGICAL GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL SURGICAL GLUE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL SURGICAL GLUE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS SURGICAL GLUE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS SURGICAL GLUE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS SURGICAL GLUE MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS SURGICAL GLUE MARKET SIZE, BY PATCH, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS SURGICAL GLUE MARKET SIZE, BY SPRAY, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS SURGICAL GLUE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS SURGICAL GLUE MARKET SIZE, BY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY PATCH, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY SPRAY, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 308. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 310. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 311. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2024 (USD MILLION)
  • TABLE 316. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2025-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2024 (USD MILLION)
  • TABLE 318. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2025-2032 (USD MILLION)
  • TABLE 319. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 320. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 321. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 322. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
  • TABLE 323. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2024 (USD MILLION)
  • TABLE 324. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY PATCH, 2025-2032 (USD MILLION)
  • TABLE 325. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2024 (USD MILLION)
  • TABLE 326. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY SPRAY, 2025-2032 (USD MILLION)
  • TABLE 327. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 329. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
  • TABLE 330. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2032 (USD MILLION)
  • TABLE 331. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 332. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 333. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 334. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 335. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 336. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 337. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
  • TABLE 338. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2032 (USD MILLION)
  • TABLE 339. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 340. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 341. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 342. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 343. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 344. EUROPE, MIDDLE E